|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
350 5th Ave Suite 5330,New York,New,US
|
|
IN8bio | 597 followers on LinkedIn. Developing the next-generation of Cellular Therapies for Cancer
| IN8bio Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems, and can intrinsically differentiate between healthy and diseased tissue. IN8bio develops ex vivo-expanded and activated gamma-delta T cell based upon its deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform.
|
IN8bio Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used IN8bio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact IN8bio customer service number in your country click here to find.
William Ho is the CEO of IN8bio. To contact William Ho email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.